Bidirectional signaling links the Abelson kinases to the platelet-derived growth factor receptor

被引:61
|
作者
Plattner, R
Koleske, AJ
Kazlauskas, A
Pendergast, AM [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA
[2] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA
[3] Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA 02114 USA
关键词
D O I
10.1128/mcb.24.6.2573-2583.2004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The c-Abl nonreceptor tyrosine kinase is activated by growth factor signals such as the platelet-derived growth factor (PDGF) and functions downstream of the PDGF-P receptor (PDGFR) to mediate biological processes such as membrane ruffling, mitogenesis, and chemotaxis. Here, we show that the related kinase Arg is activated downstream of PDGFRs in a manner dependent on Src family kinases and phospholipase C gamma1 (PLC-gamma1)-mediated phosphatidylinositol 4,5-bisphosphate (PIP2) hydrolysis, as we showed previously for c-Abl. PIP2, a highly abundant phosphoinositide known to regulate cytoskeletal and membrane proteins, inhibits the tyrosine kinase activities of both Arg and c-Abl in vitro and in cells. We now demonstrate that c-Abl and Arg form inducible complexes with and are phosphorylated by the PDGFR tyrosine kinase in vitro and in vivo. Moreover, c-Abl and Arg, in turn, phosphorylate the PDGFR. We show that c-Abl and Arg exhibit nonredundant functions downstream of the activated PDGFR. Reintroduction of c-Abl into Arg-Abl double-null fibroblasts rescues the ability of PLC-gamma1 to increase PDGF-mediated chemotaxis, while reexpression of Arg fails to rescue the chemotaxis defect. These data show that, although both kinases are activated and form complexes with proteins in the PDGFR signaling pathway, only c-Abl functions downstream of PLC-gamma1 to mediate chemotaxis.
引用
收藏
页码:2573 / 2583
页数:11
相关论文
共 50 条
  • [31] Chemosensitization by STI571 targeting the platelet-derived growth factor/platelet-derived growth factor receptor-signaling pathway in the tumor progression and angiogenesis of gastric carcinoma
    Kim, R
    Emi, M
    Arihiro, K
    Tanabe, K
    Uchida, Y
    Toge, T
    CANCER, 2005, 103 (09) : 1800 - 1809
  • [32] Blocking platelet-derived growth factor-D/platelet-derived growth factor receptor β signaling inhibits human renal cell carcinoma progression in an orthotopic mouse model
    Xu, L
    Tong, R
    Cochran, DM
    Jain, RK
    CANCER RESEARCH, 2005, 65 (13) : 5711 - 5719
  • [33] Expression of epidermal growth factor receptor and platelet-derived growth factor receptor in prostate cancer
    Jeong, CW
    Kwak, C
    Lee, SE
    JOURNAL OF UROLOGY, 2006, 175 (04): : 87 - 88
  • [34] Receptor tyrosine kinases as rational targets for prostate cancer treatment: Platelet-derived growth factor receptor and imatinib mesylate
    George, DJ
    UROLOGY, 2002, 60 (3A) : 115 - 121
  • [35] METHODS FOR STUDYING THE PLATELET-DERIVED GROWTH-FACTOR RECEPTOR
    BOWENPOPE, DF
    ROSS, R
    METHODS IN ENZYMOLOGY, 1985, 109 : 69 - 100
  • [36] SIGNAL TRANSDUCTION BY THE PLATELET-DERIVED GROWTH-FACTOR RECEPTOR
    WILLIAMS, LT
    ESCOBEDO, JA
    KEATING, MT
    COUGHLIN, SR
    COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1988, 53 : 455 - 465
  • [37] CHARACTERIZATION OF THE FIBROBLAST RECEPTOR FOR PLATELET-DERIVED GROWTH-FACTOR
    HELDIN, CH
    EK, B
    RONNSTRAND, L
    CELL BIOLOGY INTERNATIONAL REPORTS, 1983, 7 (07) : 543 - 544
  • [38] Selective inhibition of platelet-derived growth factor receptor activity
    MacEwen, EG
    COMPENDIUM ON CONTINUING EDUCATION FOR THE PRACTICING VETERINARIAN, 2000, 22 (09): : 800 - 800
  • [39] Platelet-derived growth factor receptor alpha: structure and function
    Bayley, C. P.
    Baldock, C.
    Day, A. J.
    Shuttleworth, C. A.
    Kielty, C. M.
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2010, 91 (06) : A33 - A34
  • [40] Platelet-Derived Growth Factor Receptor β Promotes Cataract Formation
    Chandler, Heather L.
    Geisler, Jennifer A.
    Sizemore, Gina M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)